Echo's glucose monitoring device shows positive trial results

12/7/2011 | Reuters

Echo Therapeutics said its Symphony tCGM device demonstrated a high accuracy rating in monitoring blood glucose levels and reported no adverse events in a clinical trial involving 20 patients with type 1 or type 2 diabetes. According to the study, 94.4% of the more than 2,600 glucose readings gathered using the device were found to be clinically accurate.

View Full Article in:

Reuters

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC
Sr Product Manager Global Marketing (US/DA/00/0085/SL) - 14000009V3
Abbott
Chicago, IL
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Vice President, Information Technology
HealthPartners
MN